[1]艾文婷a,杜 洁b,陈新军c,等.高三酰甘油者血清2-己基-环丙烷辛酸甲酯变化及分析[J].现代检验医学杂志,2017,32(05):19-23.[doi:10.3969/j.issn.1671-7414.2017.05.006]
　AI Wen-tinga,DU Jieb,CHEN Xin-junc,et al.Clinical Significance of Serum Level of Cyclopropaneoctanoic Acid 2-Hexyl in Patients with Hypertriglyceridemia-Related Disorders[J].Journal of Modern Laboratory Medicine,2017,32(05):19-23.[doi:10.3969/j.issn.1671-7414.2017.05.006]
点击复制

高三酰甘油者血清2-己基-环丙烷辛酸甲酯变化及分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第32卷
期数:
2017年05期
页码:
19-23
栏目:
论著
出版日期:
2017-11-02

文章信息/Info

Title:
Clinical Significance of Serum Level of Cyclopropaneoctanoic Acid 2-Hexyl in Patients with Hypertriglyceridemia-Related Disorders
文章编号:
1671-7414(2017)05-019-05
作者:
艾文婷a; 杜 洁b; 陈新军c; 姜保周c; 李秀红a
陕西省人民医院a.心内科; b.体检中心; c.急诊科,西安 710068
Author(s):
AI Wen-tinga; DU Jieb; CHEN Xin-junc; JIANG Bao-zhouc; LI Xiu-honga (a
a.Department of Cardiology; b.Health Examination Center; c.Department of Emergency,Shaanxi Provincial People's Hospital,Xi'an 710068,China
关键词:
高三酰甘油;  2-己基-环丙烷辛酸甲酯;  肥胖症;  慢性肾病
分类号:
R589.2; R446.112
DOI:
10.3969/j.issn.1671-7414.2017.05.006
文献标志码:
A
摘要:
目的 观察高三酰甘油相关疾病患者血清2-己基-环丙烷辛酸甲酯(CPOA2H)水平变化并探讨其临床意义。方法 选取2013年3月～2015年12月陕西省人民医院收治的临床资料完整的单纯肥胖症女性患者53例(肥胖组)、肥胖症经3个月低卡路里食物饮食者62例(肥胖低卡路里饮食组)、慢性肾病患者46例(慢性肾病组)、健康体检者60例(对照组)。气相色谱-质谱法(GC-MS)检测血清脂肪酸和CPOA2H含量。结果 四组年龄、体重指数(BMI)、C反应蛋白(CRP)、总胆固醇(TC)、总三酰甘油(TAG)差异具有统计学意义(F=6.85～25.36,均P<0.05); 肥胖组多数饱和脂肪酸(14:0,16:0)和单不饱和脂肪酸(14:1,16:1,18:1,20:1)均显著高于对照组(F=3.251～7.351,P<0.05); 慢性肾病组多不饱和脂肪酸(18:2n-6,20:4n-6)显著低于对照组(F=4.351～6.251,P<0.05); 四组血清CPOA2H水平差异具有统计学意义(F=19.95,P=0.005); 对照组(r=0.63,P=0.033)和慢性肾病组(r=0.61,P=0.044)血清CPOA2H浓度与TAG正相关,肥胖组和肥胖低卡路里饮食组血清CPOA2H浓度与TC(r=0.70,P=0.011; r=0.48,P=0.021),TAG呈正相关(r=0.75,P=0.024; r=0.72,P=0.018)。结论 高三酰甘油的肥胖症和慢性肾病患者血清CPOA2H升高,血清CPOA2H与TAG正相关,与BMI无关。
Abstract:
Abstract:Objective To observe the serum level of cyclopropaneoctanoic acid 2-hexyl(CPOA2H)in patients with hypertrilyceridemia-related disorders,and investigate its clinical significance.Methods 53 obese patients(Obese group),62 obese patients after a 3 month low calorie diet(Obese patients after low calorie diet group),46 patients with chronic kidney disease(CKD group),and 60 healthy controls(Control group)were collected from Mar 2013 to Dec 2015 in Shaanxi Provincial People's Hospital.Gaschromatography-mass spectrometry(GC-MS)were used to detect the serum fatty acid and CPOA2H level in four groups.Results Ages,body mass index(BMI),C-reaction protein(CRP),total cholesterol(TC),triacylglycerols(TAG)among four groups had significant difference(F=6.85～25.36,P<0.05).Most saturated fatty acid(14:0,16:0)and monounsaturated fatty acid(14:1,16:1,18:1,20:1)in obese group were higher than controls(F=3.251～7.351,P<0.05).The polyunsaturated fatty acid(18:2n-6,20:4n-6)inCKD group were lower than controls(F=4.351～6.251,P<0.05).There existed significant difference of serum levels of CPOA2H among four group(F=19.95,P=0.005).Serum level of CPOA2H in control(r=0.63,P=0.033)and CKDgroup(r=0.61,P=0.044)were positively related with TAG.Serum level of CPOA2H in obese group and obese patients after low calorie diet group were positively related with TC(r=0.70,P=0.011; r=0.48,P=0.021)and TAG(r=0.75,P=0.024; r=0.72,P=0.018).Conclusion Hypertrilyceridemia-related disorders,such as obesity and CKD,presented with elevated serum levels of CPOA2H,it suggested that serum level of CPOA2H is positively related to serum TAG concentration rather than BMI.

参考文献/References:

[1] Poger D,Mark AE.A ring to rule them all:the effect of cyclopropane fatty acids on the fluidity of lipid bilayers[J].J Phys Chem B,2015,119(17):5487-5495.
[2] Sedger LM,Tull DL,McConville MJ,et al.Lipidomic profiling of adiposetissue reveals an inflammatory signature in cancer-related and primary lymphedema[J].PLoS One,2016,11(5):e0154650.
[3] Kadegowda AK,Burns TA,Pratt SL,et al.Inhibition of stearoyl-CoA desaturase 1 reduces lipogenesis in primary bovine adipocytes[J].Lipids,2013,48(10):967-976.
[4] Sledzinski T,Miko A,Stenowski P,et al.Identification of cyclopropaneoctanoic acid 2-hexyl in human adipose tissue and serum[J].Lipids,2013,48(8):839-848.
[5] 中华医学会外科分会内分泌外科学组,中华医学会外科学分会腹腔镜与内镜外科学组,中华医学会外科学分会胃肠外科学组,等.中国肥胖病治疗指南(2007)[J].中国实用外科杂志,2007,27(10):759-762. Outside the Science Branch of Endocrine Surgery Group of Chinese Medical Association,Chinese Society of Surgery,Laparosopic and Endoscopic Surgery Group of Chinese Medical Association,Gastrointestinal Surgery Society of Chinese Medical Association,et al.Guidelines for surgical treatment of obesity in China(2007)[J].Chin J Pract Surg,2007,27(10):759-762.
[6] Snyder S,Pendergraph B.Detection and evaluation of chronic kidney disease[J].American Family Physician,2005,72(9):1723-1732.
[7] 王继贵.基质金属蛋白酶和代谢综合征的研究进展[J].现代检验医学杂志,2015,30(3):1-4. Wang JG.Progress of research on matrix metalloproteinases and metabolic syndrome[J].J Mod Lab Med,2015,30(3):1-4.
[8] 张允奇,陆学东,张银辉,等.SLE患者血清胱抑素C与血脂的相关性分析[J].现代检验医学杂志,2015,30(4):63-66. Zhang YQ,Lu XD,Zhang YH,et al.Correlation analysis of serum cystatin C and lipids levels in patients with systemic lupus erythematosus[J].J Mod Lab Med,2015,30(4):63-66.
[9] 李雪群,严凤好,蓝建崇,等.腰围与体重指数对无偿献血者脂肪血的预测价值[J].现代检验医学杂志,2016,31(4):136-138. Li XQ,Yan FH,Lan JC,et al.Predictive value of waist circumference and body mass index in lipemic donation[J].J Mod Lab Med,2016,31(4):136-138.
[10] Vaziri ND.Disorders of lipid metabolism in nephrotic syndrome:mechanisms and consequences[J].Kidney Int,2016,90(1):41-52.
[11] Caligiani A,Marseglia A,Palla G.An overview on the presence of cyclopropane fatty acids in milk and dairy products[J].J Agric Food Chem,2014,62(31):7828-7832.
[12] Crescenzo R,Mazzoli A,Cancelliere R,et al.Polyunsaturated fatty acids stimulate de novo lipogenesis and improve glucose homeostasis during refeedingwith high fat diet[J].Front Physiol,2017(8):178.
[13] Chen H,Chen L,Liu D,et al.Combined clinical phenotype and lipidomicanalysis reveals the impact of chronic kidney disease on lipid metabolism[J].J Proteome Res,2017,16(4):1566-1578.
[14] 柏 琳,于海涛,国春玲,等.慢性肾病患者血清总胆红素水平临床变化意义及分析[J].中国现代药物应用,2017,11(4):68-69. Bo L,Yu GT,Guo CL,et al.Clinical analysis of serum total bilirubin in patients with chronic kidney disease[J].Chin J Mod Drug Appl,2017,11(4):68-69.
[15] 解加泳.血清低密度脂蛋白胆固醇对慢性肾病患者病情进展的影响[J].检验医学与临床,2015,12(16):2418-2420. Xie JY.Influence of serum low-density lipoprotein cholesterol level on disease progression in patients with chronic kidney disease[J].Lab Med Clin,2015,12(16):2418-2420.

备注/Memo

备注/Memo:
作者简介:艾文婷(1979-),女,硕士,副主任医师,研究方向:心力衰竭,动脉粥样硬化,E-mail:aiwent123ing@163.com。 通讯作者:李秀红,本科,主管护师,研究方向:心血管内科,E-mail:13088967076@163.com。
更新日期/Last Update: 1900-01-01